COL1A1 and metabolic dysfunction-associated steatohepatitis: The robust weight loss GAN DIO-NASH mice was paralleled by robust improvements in metabolic markers, NAS and fibrosis histomorphometry (PSR, Col1a1), but not fibrosis stage even after 24 weeks of dietary intervention.